These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20470294)

  • 1. How to apply results from randomized trials and systematic reviews to individual patient care.
    Hodson EM; Craig JC
    Nephrology (Carlton); 2010 Apr; 15(3):277-80. PubMed ID: 20470294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing benefits and harms in health care: observational data on harm should complement systematic reviews of benefit.
    Vandenbroucke JP
    BMJ; 2003 Sep; 327(7417):750. PubMed ID: 14512491
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting of harm in randomized controlled trials published in the urological literature.
    Breau RH; Gaboury I; Scales CD; Fesperman SF; Watterson JD; Dahm P
    J Urol; 2010 May; 183(5):1693-7. PubMed ID: 20299044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communicating the benefits and harms of treatments.
    Akobeng AK
    Arch Dis Child; 2008 Aug; 93(8):710-3. PubMed ID: 18456681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to read a report of a randomized controlled trial.
    Jun M; Zoungas S; Perkovic V; Webster AC
    Nephrology (Carlton); 2010 Mar; 15(2):153-7. PubMed ID: 20470272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endarterectomy for preventing stroke in symptomatic and asymptomatic carotid stenosis. Review of clinical trials and recommendations for surgical therapy.
    Levinson MM; Rodriguez DI
    Heart Surg Forum; 1999; 2(2):147-68. PubMed ID: 11276473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program.
    Chou R; Aronson N; Atkins D; Ismaila AS; Santaguida P; Smith DH; Whitlock E; Wilt TJ; Moher D
    J Clin Epidemiol; 2010 May; 63(5):502-12. PubMed ID: 18823754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to use a systematic literature review and meta-analysis.
    Tseng TY; Dahm P; Poolman RW; Preminger GM; Canales BJ; Montori VM
    J Urol; 2008 Oct; 180(4):1249-56. PubMed ID: 18707741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
    Sobel BE
    Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of large-scale evidence on specific harms from systematic reviews of randomized trials.
    Papanikolaou PN; Ioannidis JP
    Am J Med; 2004 Oct; 117(8):582-9. PubMed ID: 15465507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical appraisal of trials for validation of 'risk-guided' cardiovascular disease prevention therapy.
    Castro A; Rosillo SO; Alonso A; Pedersen T
    Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):33-6. PubMed ID: 22801068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perils of evidence-based medicine.
    Williams BA
    Perspect Biol Med; 2010; 53(1):106-20. PubMed ID: 20173299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies.
    Papanikolaou PN; Christidi GD; Ioannidis JP
    CMAJ; 2006 Feb; 174(5):635-41. PubMed ID: 16505459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based medicine targets the individual patient, part 1: how clinicians can use study results to determine optimal individual care.
    Bassler D; Busse JW; Karanicolas PJ; Guyatt GH
    Evid Based Med; 2008 Aug; 13(4):101-2. PubMed ID: 18667659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.